Riskpilot← Back to searchSign inGet full accessROCHE NORGE AS
ASActiveOrg 935925525Brynsengfaret 6B, 0667 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 198445 employees
Revenue 2024
NOK 706,7M
+21% vs 2023
EBITDA margin
3.4%
+20% vs 2023
Equity ratio
36.6%
Financial strength
Net profit 2024
NOK 17,5M
+24% vs 2023
| Revenue | NOK 706,7M | +21% |
| EBITDA | NOK 23,9M | +20% |
| Net profit | NOK 17,5M | +24% |
| Total assets | NOK 247,3M | +0% |
| Equity | NOK 90,5M | +24% |
| Employees | 45 | — |
Legal name
ROCHE NORGE AS
Org number
935925525
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
6. november 1984
Share capital
NOK 6 160 000
Employees
45 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Brynsengfaret 6B, 0667 Oslo
Phone
+4723373300
Email
pharma.norge@roche.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 547 313 | 510 921 | 535 240 | 582 155 | 706 693 |
| Staff expenses | −94 363 | −86 854 | −85 804 | −79 482 | −83 470 |
| EBITDA | 25 067 | 20 121 | 10 746 | 19 951 | 23 895 |
| Depreciation & amort. | −670 | −315 | −312 | −303 | −282 |
| EBIT | 24 397 | 19 806 | 10 434 | 19 648 | 23 613 |
| Net financials | −682 | −114 | −1 063 | −1 405 | −922 |
| Profit before tax | 23 715 | 19 692 | 9 371 | 18 243 | 22 691 |
| Tax | 5 529 | 4 338 | 2 189 | 4 181 | 5 236 |
| Net profit | 18 186 | 15 354 | 7 182 | 14 062 | 17 455 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 215 615 | 199 105 | 192 721 | 247 544 | 247 333 |
| Equity | 36 176 | 51 530 | 58 705 | 72 767 | 90 495 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 179 437 | 147 575 | 134 016 | 174 777 | 156 838 |
| Total debt | 179 437 | 147 575 | 134 016 | 174 777 | 156 838 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
36.6%
This company
38.2%
Market median
+4% vs market
20202024
Return on equity
19.3%
This company
18.4%
Market median
+5% vs market
20202024
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20202024
Asset turnover
2.86×
This company
1.12×
Market median
+155% vs market
20202024
Debt / equity
1.73×
This company
0.62×
Market median
-179% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MW Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
RJ Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
RM Chief Executive Officer | Chief Executive Officer | 2018 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Former (5) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2022 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Roche Holding Ltd | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROCHE NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Wiliam George Haswell | Chief Executive Officer | 0 companies |
| Richard John Wright | Chief Executive Officer | 0 companies |
| Rajwinder Mehdwan | Chief Executive Officer | 0 companies |
| Isabel Marianne Joerin | Chairman | 0 companies |
| Daniel Andrzej Malarek | Board of Directors | 0 companies |
| Ellen Margrethe Eidal | Board of Directors | 0 companies |
| Beat Christoph Krähenmann | Chairman | 0 companies |
| Jakob Rosenkilde Butina | Board of Directors | 0 companies |
| Isabel Marianne Boissonnas | Chairman | 0 companies |
| Paula Aguiar | Board of Directors | 0 companies |
| Ehab Abdelmoneim Youssef Hassan | Board of Directors | 0 companies |